Methyl palmoxirate increases Ca2+-myosin ATPase activity and changes myosin isoenzyme distribution in the diabetic rat heart - PubMed (original) (raw)

Methyl palmoxirate increases Ca2+-myosin ATPase activity and changes myosin isoenzyme distribution in the diabetic rat heart

W H Dillmann. Am J Physiol. 1985 May.

Abstract

Previous studies have shown that in rats diabetes mellitus leads to a decrease in cardiac ventricle myosin V1 and an increase in myosin V3 levels. Insulin administration reverts myosin isoenzyme distribution to normal levels. It is currently unclear whether the effects of insulin on myosin isoenzyme distribution are a direct effect of the hormone or are mediated through insulin-induced alterations in cardiac metabolism. To gain further insight into this question diabetic rats received methyl palmoxirate, a potent inhibitor of long-chain fatty acid oxidation. Administration of 25 mg methyl palmoxirate X kg body wt-1 X day-1 to diabetic rats for 4 wk leads to a partial reversal of the effects of diabetes. Myosin V1 predominance is re-established and Ca2+-activated myosin ATPase activity increases by 60% (Ca2+-myosin ATPase normal rats 1.067 +/- 0.13 mumol Pi X mg protein-1 X min-1, diabetic rats 0.609 +/- 0.05 mumol Pi X mg protein-1 X min-1, diabetic + methyl palmoxirate rats 0.912 +/- 0.06 mumol Pi X mg protein-1 X min-1). The methyl palmoxirate-induced increase in myosin V1 levels and Ca2+-activated myosin ATPase activity occurred in the absence of changes in insulin and thyroid hormone levels. Methyl palmoxirate may have acted through its known inhibitory effect on cardiac beta-oxidation and/or the resultant stimulatory effect on glycolytic flux. Our findings may indicate that changes in cardiac substrate consumption can influence myosin isoenzyme predominance.

PubMed Disclaimer

Cited by

Effects of exercise training and diabetes on cardiac myosin heavy chain composition.
Paulson DJ, Gupta M, Zak R, Zhao J. Paulson DJ, et al. Mol Cell Biochem. 1992 Nov 18;117(2):175-9. doi: 10.1007/BF00230757. Mol Cell Biochem. 1992. PMID: 1488051
Modification of myosin isozymes and SR Ca(2+)-pump ATPase of the diabetic rat heart by lipid-lowering interventions.
Rupp H, Elimban V, Dhalla NS. Rupp H, et al. Mol Cell Biochem. 1994 Mar 16;132(1):69-80. doi: 10.1007/BF00925676. Mol Cell Biochem. 1994. PMID: 8078510
Factors controlling cardiac myosin-isoform shift during hypertrophy and heart failure.
Gupta MP. Gupta MP. J Mol Cell Cardiol. 2007 Oct;43(4):388-403. doi: 10.1016/j.yjmcc.2007.07.045. Epub 2007 Jul 21. J Mol Cell Cardiol. 2007. PMID: 17720186 Free PMC article. Review.
Metabolic abnormalities in the diabetic heart.
Lopaschuk GD. Lopaschuk GD. Heart Fail Rev. 2002 Apr;7(2):149-59. doi: 10.1023/a:1015328625394. Heart Fail Rev. 2002. PMID: 11988639 Review.
Proposed regulation of gene expression by glucose in rodent heart.
Young ME, Yan J, Razeghi P, Cooksey RC, Guthrie PH, Stepkowski SM, McClain DA, Tian R, Taegtmeyer H. Young ME, et al. Gene Regul Syst Bio. 2007 Nov 5;1:251-62. doi: 10.4137/grsb.s222. Gene Regul Syst Bio. 2007. PMID: 19936093 Free PMC article.

Methyl palmoxirate increases Ca2+-myosin ATPase activity and changes myosin isoenzyme distribution in the diabetic rat heart - PubMed (original) (raw)